WuXi PharmaTech Co., Ltd. Reports Higher Q1; Analyzes Prospects for Its Business

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!



by Richard Daverman, PhD

May 14, 2013 -- WuXi PharmaTech released positive financial results for the first quarter of 2013, as revenues increased 11.7% to $132 million. All sectors of the company’s CRO/CMO business contributed to the climb. In remarks to analysts, Ge Li, the company's Chairman and CEO, conducted an interesting discussion of WuXi’s various business units, shedding light on each one’s performance and potential for growth in the next few years. More details....

Stock Symbol: (NYSE: WX)

Help employers find you! Check out all the jobs and post your resume.